NEO-STIM
Dead / Abandoned — Abandoned — no statement of use filed (as of 26 Sept 2022)
What this means for you
This application is over — abandoned 26 Sept 2022. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88000880
- Mark type
- Stylized text
- Filed
- 14 Jun 2018
- Published for opposition
- 25 Jun 2019
- Abandoned
- 26 Sept 2022
- Attorney of record
- Monica Riva Talley
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals, namely, immunotherapies for the treatment of cancer and oncological conditions; oncological preparations, namely, pharmaceutical products for the detection, prevention, and treatment of cancer; anti-cancer preparations; biological preparations for the treatment of cancer and oncological conditions; pharmaceutical products for the prevention and treatment of cancer and oncological conditions; synthetic peptides for the treatment of cancer and oncological conditions; and vaccine preparations; medical assays for testing of body fluids
Owner
- BioNTech US Inc., Cambridge, MA, US
- Neon Therapeutics, Inc., Cambridge, MA, US
- Neon Therapeutics, Inc., Cambridge, MA, US
Prosecution history
- 26 Sept 2022 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 26 Sept 2022 — ABANDONMENT - NO USE STATEMENT FILED
- 28 Jan 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 27 Jan 2022 — SOU EXTENSION 5 GRANTED
- 25 Jan 2022 — SOU EXTENSION 5 FILED
- 25 Jan 2022 — SOU TEAS EXTENSION RECEIVED
- 28 Dec 2021 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 28 Dec 2021 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 28 Dec 2021 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 19 Aug 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 17 Aug 2021 — SOU EXTENSION 4 GRANTED
- 17 Aug 2021 — SOU EXTENSION 4 FILED
- 17 Aug 2021 — SOU TEAS EXTENSION RECEIVED
- 15 Apr 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 14 Apr 2021 — SOU EXTENSION 3 GRANTED